May 07, 2020
Nektar Therapeutics Reports First Quarter 2020 Financial Results
Feb 28, 2020
Nektar Therapeutics to Webcast Presentation at the Cowen and Company 40th Annual Health Care Conference
Feb 28, 2020
Nektar Therapeutics to Webcast Presentation at the Cowen and Company 40th Annual Health Care Conference
Feb 18, 2020
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2019 on Thursday, February 27, 2020, After Close of U.S.-Based Financial Markets
Dec 03, 2019
Nektar Appoints John Northcott as Chief Commercial Officer
Nov 06, 2019
Nektar Therapeutics Reports Financial Results for the Third Quarter of 2019
Nov 01, 2019
Nektar Therapeutics to Host Webcast Conference Call with Melanoma Specialist for Analysts & Investors During 2019 Society for Immunotherapy of Cancer 34th Annual Meeting
Oct 30, 2019
Nektar to Announce Financial Results for the Third Quarter 2019 on Wednesday, November 6, 2019, After Close of U.S.-Based Financial Markets
Oct 01, 2019
Nektar Announces Key Executive Promotions
Sep 23, 2019
Nektar Therapeutics Announces Abstract Accepted for Presentation at the 5th CRI-CIMT-EATI-AACR Cancer Immunotherapy Conference
Aug 22, 2019
INVESTOR ALERT - Nektar Therapeutics (NKTR) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Plaintiff Deadline: October 18, 2019
Jul 30, 2019
Nektar to Announce Financial Results for the Second Quarter 2019 on Thursday, August 8, 2019, After Close of U.S.-Based Financial Markets
May 23, 2019
Nektar Announces the Launch of Inheris Biopharma, Inc.
May 01, 2019
Nektar to Announce Financial Results for the First Quarter 2019 on Wednesday, May 8, 2019, After Close of U.S.-Based Financial Markets
Mar 06, 2019
Nektar Therapeutics to Webcast Presentation at the Cowen and Company 39th Annual Health Care Conference
Feb 28, 2019
Nektar Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
Feb 25, 2019
Nektar Therapeutics to Webcast Conference Call for Analysts and Investors at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Feb 21, 2019
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2018 on Thursday, February 28, 2019, After Close of U.S.-Based Financial Markets
Feb 11, 2019
Nektar Therapeutics to Webcast Conference Call with Urothelial Cancer Specialist for Analysts & Investors at the 2019 ASCO Genitourinary Cancers Symposium
Dec 27, 2018
Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA